Dissociative delirium after treatment with lysergide.
D000328:Adult; D003693:Delirium / Q000139:chemically induced*; D004213:Dissociative Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects* / Q000627:therapeutic use; D009497:Neurotic Disorders / Q000188:drug therapy; D011605:Psychoses, Substance-Induced
D008238:Lysergic Acid Diethylamide